Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
2021 · Nature Communications · 101 citations
https://doi.org/10.1038/s41467-021-24963-3
Y
Yong Joon Kim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
989
Citations
17
h-index
36
i10-index
Yong Joon Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Retinal and Optic Conditions & Retinal Diseases and Treatments & Ocular Oncology and Treatments. The author has an h-index of 17, co-authored 106 publications.
ORCID: 0000-0001-6090-2549Papers by this author
worksYAP Activity is Not Associated with Survival of Uveal Melanoma Patients and Cell Lines
2020 · Scientific Reports · 33 citations
https://doi.org/10.1038/s41598-020-63391-z
Distributional characteristics of the mRNA for retinoid Z receptor β (RZRβ), a putative nuclear melatonin receptor, in the rat brain and spinal cord
1997 · Brain Research · 25 citations
https://doi.org/10.1016/s0006-8993(96)01320-0
Characterization of Ginkgo biloba Leaf Flavonoids as Neuroexocytosis Regulators
2020 · Molecules · 22 citations
https://doi.org/10.3390/molecules25081829
Retinal vascular occlusion risks during the COVID-19 pandemic and after SARS-CoV-2 infection
2023 · Scientific Reports · 14 citations
https://doi.org/10.1038/s41598-023-44199-z
Real‐World Incidence of Incident Noninfectious Uveitis in Patients Treated With BRAF Inhibitors: A Nationwide Clinical Cohort Study
2024 · American Journal of Ophthalmology · 12 citations
https://doi.org/10.1016/j.ajo.2024.07.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat